en en en en de en en en sv en fr gl ca en sv en fr hu en en fr fr en en war en en de en en it it en en it en en en en en en en en en en en km en km en en en en km en en en km en km en en en en en en de pt en en vi km en en en en en en en en en en
Venus Legacy technology delivers Multipolar Radio Frequency and Magnetic Pulse Therapy to the skin to produce a dense and uniform heat matrix. This causes collagen synthesis and contraction, fibroblast proliferation, neovascularity and lipolysis.
This treatment is non-invasive and pain-free. It works!
We all know that it becomes hard to lose fat with age. This is true no matter what your body shape, skin tone, diet or exercise plan is. We also develop cellulite. Venus Legacy is a nonsurgical facial and body contouring treatment that reduces inches, smoothes, and diminishes cellulite.
Venus Legacy will reduce inches, reshape and re-contour the skin, and smooth dimpled skin.
Contour and flatten your abdomen for a flatter, defined stomach. Contour stubborn fat pockets to reduce bra bulge. Target your thighs to reduce cellulite and circumference, while smoothing and shaping. Lift your buttocks for better shape.
By increasing tissue temperature, fat cells are broken down and fatty acids are freed from the fat cells. Thus, volume can be reduced producing circumferential reduction. The blood flow in the treated area is also improved which helps to enhance skin tone and texture.
This treatment is designed to be pain free.
The applicators deliver heat beneath the skin to break down deep-levels of fatty tissue. Some individuals find it to be comforting and relaxing. A treatment to one area takes less than 30 minutes, and has no adverse side effects. You are able to have a treatment on your lunch break and return to work right away.
Most patients typically see results after the third treatment, however many have noted results even sooner. Venus Legacy is FDA-approved and has documented results that last a minimum 18 months, but will continue to last if maintenance treatments are done.